Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation.
about
Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant CyclophosphamideDonor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell TransplantationModern approaches to HLA-haploidentical blood or marrow transplantationHaploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular TherapyHeat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models.Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice.Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide.OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantationPost-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation.The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression.Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers.T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.Homeostatic expansion as a barrier to lymphocyte depletion strategies.Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes.Stability of Chimerism in Non-Obese Diabetic Mice Achieved By Rapid T Cell Depletion Is Associated With High Levels of Donor Cells Very Early After Transplant.Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation.
P2860
Q26767438-59BA2743-FD3B-4A86-B158-50DA0EE28F50Q26767440-C841DE92-D180-44E1-AFD3-B20DF3D1A390Q26797506-69BD3765-622E-4FEA-B850-926C928A4029Q28085397-0811D2E9-08D1-4447-BF38-E329A0CE5B0CQ33585305-DDDA6D09-D6AE-4885-9A99-DA257513364CQ33724352-D48C599F-8839-413F-BC65-B41A76176B16Q34170406-607251A0-FA2F-42AF-84BA-22932A5F77E6Q34293038-96D08916-7588-4881-85A3-6003CB9C3332Q35584266-1ABD1585-571C-4FC8-9F02-AB990C81BA6DQ36445665-0F8AA445-1D8B-4B07-B0C8-1C5323C89FF0Q36724916-E23EDF5B-281B-4207-B7D5-E3CBA6C2545FQ36833808-3E0E683B-4996-4C2B-878D-8DDF6804C6A9Q37029856-0FCA4E9E-3FBB-46E6-ACEA-1185FE8B2EBAQ38163428-DA613529-28F3-4071-9498-C7E3705AEB4CQ38190856-A97918AE-A22B-4A4B-8E38-A11D41BA4152Q38212957-EA24891E-7F34-46CD-9144-489788DD5A7AQ38219995-1065675B-9F67-4D56-9F66-2646115A5E16Q39176256-F7C38897-A9EE-4EFF-B6F9-A521C52BF1EEQ51783552-37928F5F-26E1-41EF-AE33-AB01842FB44CQ53824120-E31A14AB-B21F-47AE-BAC7-21BB2E9AC958Q55268453-E2B3012A-A5F1-4DDC-90E1-D3600BD6AF9F
P2860
Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antigen and lymphopenia-driven ...... opoietic cell transplantation.
@en
Antigen and lymphopenia-driven ...... opoietic cell transplantation.
@nl
type
label
Antigen and lymphopenia-driven ...... opoietic cell transplantation.
@en
Antigen and lymphopenia-driven ...... opoietic cell transplantation.
@nl
prefLabel
Antigen and lymphopenia-driven ...... opoietic cell transplantation.
@en
Antigen and lymphopenia-driven ...... opoietic cell transplantation.
@nl
P2093
P2860
P1476
Antigen and lymphopenia-driven ...... opoietic cell transplantation.
@en
P2093
Duncan Ross
Krishna Komanduri
Monica Jones
Robert B Levy
P2860
P304
P356
10.1016/J.BBMT.2013.06.019
P577
2013-06-29T00:00:00Z